ClinicalTrials.gg
Not yet recruitingNCT07892040Updated Oct 23, 2026

Comparative Effects of Exercises on Pain, Cervical Proprioception, Neck Disability and Visual Performance in Patients With Computer Vision Syndrome.

An interventional study of Cervical Sensorimotor Training and Occulomotor Training in Computer Vision Syndrome, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study aims to compare the effectiveness of cervical sensorimotor training and oculomotor training in patients with Computer Vision Syndrome (CVS). It will evaluate their effects on neck pain, cervical proprioception, neck disability, and visual performance. Both interventions aim to improve cervical neuromuscular control and visual function through targeted exercises. The findings will help identify the more effective rehabilitation approach for managing musculoskeletal and visual symptoms associated with CVS.

02

Conditions studied

  • Computer Vision Syndrome

Browse trials for

Keywords

  • Visual Fatigue
  • Cervical Sensorimotor training
  • Joint Position Error
  • Neck Disability
  • Sensorimotor Integration
  • Oculomotor Training
03

In context

Asthenopia

63 studies on the registry are indexed under Asthenopia; 10 are open to participants now.

This study's planned enrollment of 46 is below the median of 59 across 51 interventional studies indexed under Asthenopia.

Browse Asthenopia studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18-40 years.

    • Both genders.
    • Individuals using digital screens for more than 4 hours/day.
    • NPRS range between 4-6.
    • Presence of neck pain for at least 3 months
    • CVS-Q smart score 7-10.

Exclusion criteria

Exclusion Criteria:

  • History of cervical trauma or surgery.
  • Vestibular disorders.
  • Neurological disorders.
  • Cervical radiculopathy/myelopathy.
  • Diagnosed migraine disorders.
  • visual impairment corrected by lenses/glasses
  • Inflammatory cervical conditions.
  • Recent physiotherapy treatment within last 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Cervical Sensorimotor Training

    Participants will perform Neutral Return, Target Angles, and Movement Sequence exercises using laser-guided head movements, starting with 5 repetitions per movement and progressing according to tolerance. Sessions will last 30-40 minutes, 3 times per week for 8 weeks.

    Other: Cervical Sensorimotor Training

  • Active comparator
    Oculomotor Training

    Group B will receive saccadic eye movements, smooth pursuit, and gaze stabilization exercises (X1 and X2), starting at 3 minutes per exercise with weekly progression. Sessions will last 30-40 minutes, 3 times per week for 8 weeks

    Other: Occulomotor Training

Interventions

  • OtherCervical Sensorimotor Training

    Participants will perform Neutral Return, Target Angles, and Movement Sequence exercises using laser-guided head movements, starting with 5 repetitions per movement and progressing according to tolerance. Sessions will last 30-40 minutes, 3 times per week for 6 weeks.

  • OtherOcculomotor Training

    Group B will receive saccadic eye movements, smooth pursuit, and gaze stabilization exercises (X1 and X2), starting at 3 minutes per exercise with weekly progression. Sessions will last 30-40 minutes, 3 times per week for 6 weeks

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain intensity .The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).

    Time frame: Baseline and after 6 weeks post treatment

  2. Neck Disability Index

    The NDI is a self-reported questionnaire that checks how much neck pain impacts daily life. It covers 10 areas (like pain, self-care, work, and recreation), each scored from 0 to 5. A higher total (out of 50) means more disability: * 0-4: No disability * 5-14: Mild * 15-24: Moderate * 25-34: Severe Above 34: Complete disability The NDI is a reliable way to assess neck-related issues.

    Time frame: Baseline and after 6 weeks post treatment

  3. Cervical Joint Position Error Test (JPE)

    This test measures neck proprioception (body awareness). A laser pointer on the head tracks how close someone can return to their starting position after moving their head with eyes closed. The closer they get, the better their proprioception. A difference over 4.5° suggests impaired awareness. The JPE test is dependable for checking neck movement sense

    Time frame: Baseline and after 6 weeks post treatment

  4. Visual Complaint Index (VCI)

    The VCI is a questionnaire that asks about vision problems like eye strain, blurred or double vision, headaches, sensitivity to light, and fatigue-especially from screen use or neck problems. Each symptom is rated for how bad and how often it is. Multiply those scores for each symptom and add them up for a total. Higher totals mean more symptoms. The VCI helps spot issues linked to Computer Vision Syndrome and neck-related visual problems

    Time frame: Baseline and after 6 weeks post treatment

07

Study locations

1 site
  • University Medical Center
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of manuscript

Access criteria: data can be requested from corresponding author

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 30 non-industry interventional studies with no phase under Asthenopia, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 9. This study's planned 2 months is below that.

Counting every sponsor, half of 35 studies reached it within 3 months; a quarter within 1 and three quarters within 9.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2026
First posted
Oct 23, 2026
StartEst.
Oct 20, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892040
Lead sponsor
University of Management and Technology Lahore
Responsible party
Maria Mustafa (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Oct 23, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion